Erythropoietin Resistance in Anemia of Chronic Kidney Disease

Novel Biomarkers of Erythropoietin Resistant Anemia Among Patients With Chronic Kidney Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00526747

Enrollment

Registered

2007-09-10

Start date

2007-08-31

Completion date

2008-06-30

Last updated

2013-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Erythropoietin, Kidney Failure

Brief summary

Our goal of this pilot project is to identify inflammatory biomarkers that correlate with epo-resistance among CKD patients.

Interventions

None listed

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* prevalent patients greater than or equal to 18 years old with CKD defined as a glomerular filtration rate \< 60 cc/min

Exclusion criteria

* active GI bleeding or history of GI bleed in the prior 3 months * uncontrolled hyperparathyroidism (PTH\>500) * untreated iron deficiency (transferrin saturation \< 20% and ferritin \< 100 * overt infection * active hemolysis * hemoglobinopathies * known adverse response to erythropoietin * prior kidney transplant * aluminum toxicity

Countries

United States

Outcome results